Letter to the Editor

A Different Therapeutic Approach in Patients with Severe Ulcerative Colitis: Hyperbaric Oxygen Treatment

Authors: Ahmet Kemal Guumlrbuumlz, MD, Emin Elbuumlken, MD, Yusuf Yazgan, MD, Senol Yinodotldinodotz, MD

Abstract

To the Editor:


Hyperbaric oxygen treatment (HBOT) has been used in patients with some diseases of the gastrointestinal system, such as radiation enterocolitis, CD, and experimental colitis; however, the experience with HBOT in patients with ulcerative colitis (UC) is limited. 1,2 We present a case of clinical remission after HBOT in a patient with UC who did not respond to treatment with 5-amino salicylic acid, methylprednisolone, and azathioprine.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Kuroki K, Masuda A, Uehara H, Kuroki A. A new treatment for toxic megacolon. Lancet 1998; 352: 782.
 
2. Buchman AL, Fife C, Torres C, Smith L, Aristizibal J. Hyperbaric oxygen therapy for severe ulcerative colitis. J Clin Gastroenterol 2001; 33: 337–339.
 
3. Truelove SC, Richards WCD. Biopsy studies in ulcerative colitis. Br Med J 1956; 6: 1315–1318.
 
4. Webberley MJ, Hart MT, Melikian V. Thromboembolism in inflammatory bowel disease: Role of platelets. Gut 1993; 34: 247–251.
 
5. Folwaczny C, Spannagl M, Wiebecke W, Jochum M, Heldwein W, Loeschke K. Heparin in the treatment of highly active inflammatory bowel disease. Gastroenterology 1996; 110( 4): A908(abstract).